Sponsor Dossier
Dr Reddys Laboratories
Sponsor Dossier for Dr Reddys Laboratories. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ABIRATERONE
- Brand: ABIRATERONE-DRLA
- Brand: ABIRATERONE-REDDY'S
- Brand: ACLONAT
- Brand: AMCAL
- Brand: APO-TERIFLUNOMIDE
- Brand: APX-SILDENAFIL
- Brand: ARX-ABIRATERONE
About
Dr Reddys Laboratories is an Australian Private Company with ABN 16 120 092 408, registered in Victoria. The company is currently active.
Portfolio
Dr Reddys Laboratories holds 105 brands on the ARTG, of which 46 are indexable. The company has 39 brands with Product Information on file, 5 brands with at least one PBS-listed item, 7 brands with PBAC outcome records, and 4 brands with AusPAR records.
Therapeutic focus
— Oncology: 39 brands — Neurology: 19 brands — Urology: 10 brands — Respiratory: 6 brands — Haematology: 6 brands — Infectious Disease: 6 brands — Rare Disease: 4 brands — Endocrinology: 4 brands — Gastroenterology: 3 brands — Cardiology: 2 brands — Psychiatry: 1 brand — Dermatology: 1 brand — Immunology: 1 brand — Women's Health: 1 brand — Ophthalmology: 1 brand — Other: 1 brand
PBS footprint
Five brands in Dr Reddys Laboratories' portfolio hold at least one PBS-listed item. The latest PBS schedule date the portfolio touched was 1 May 2026.
Regulatory activity
Dr Reddys Laboratories has 7 brands with PBAC outcomes on record, with the latest outcome dated 1 March 2025. The company has 4 brands with AusPAR records, with the latest AusPAR dated 15 February 2021.